|
1
|
Accelerated blood clearance phenomenon upon repeated injection of PEG-modified PLA-nanoparticles.
|
Pharm Res
|
2009
|
1.23
|
|
2
|
Therapeutic effect of lecithinized superoxide dismutase against colitis.
|
J Pharmacol Exp Ther
|
2008
|
1.01
|
|
3
|
Mature adipocyte-derived cells, dedifferentiated fat cells (DFAT), promoted functional recovery from spinal cord injury-induced motor dysfunction in rats.
|
Cell Transplant
|
2008
|
0.99
|
|
4
|
Efficient targeting to alveolar macrophages by intratracheal administration of mannosylated liposomes in rats.
|
J Control Release
|
2007
|
0.95
|
|
5
|
Octaarginine-modified liposomes enhance the anti-oxidant effect of Lecithinized superoxide dismutase by increasing its cellular uptake.
|
Biochem Biophys Res Commun
|
2010
|
0.83
|
|
6
|
Successful treatment of photo-damaged skin of nano-scale atRA particles using a novel transdermal delivery.
|
J Control Release
|
2005
|
0.83
|
|
7
|
Synthesis of prostaglandin E(1) phosphate derivatives and their encapsulation in biodegradable nanoparticles.
|
Pharm Res
|
2009
|
0.78
|
|
8
|
Cell therapy with adipose tissue-derived stem/stromal cells for elastase-induced pulmonary emphysema in rats.
|
Regen Med
|
2012
|
0.78
|
|
9
|
Lecithinized brain-derived neurotrophic factor promotes the differentiation of embryonic stem cells in vitro and in vivo.
|
Biochem Biophys Res Commun
|
2005
|
0.77
|
|
10
|
Prolonging the in vivo residence time of prostaglandin E(1) with biodegradable nanoparticles.
|
Pharm Res
|
2008
|
0.76
|
|
11
|
Improvement of hind-limb paralysis following traumatic spinal cord injury in rats by grafting normal human keratinocytes: new cell-therapy strategy for nerve regeneration.
|
J Artif Organs
|
2011
|
0.76
|
|
12
|
Prostaglandin E1 -containing nanoparticles improve walking activity in an experimental rat model of intermittent claudication.
|
J Pharm Pharmacol
|
2013
|
0.75
|
|
13
|
Brain-derived neurotrophic factor bound with lecithin derivative showed a markedly enhanced pharmacological potency due to its potent cell membrane affinity followed by prolonged MAPK activation.
|
J Control Release
|
2005
|
0.75
|
|
14
|
[Prolonged release microcapsules of insulin for complement of the basal secretion].
|
Nihon Rinsho
|
2002
|
0.75
|
|
15
|
Anti-tuberculosis activity and drug interaction with nevirapine of inhalable lipid microspheres containing rifampicin in murine model.
|
J Microencapsul
|
2010
|
0.75
|